中牧股份(600195.SH)：拟放弃控股子公司股权优先购买权

Core Viewpoint - The company, Zhongmu Co., Ltd. (中牧股份), has established a joint venture named Zhongpu Biopharmaceutical Co., Ltd. (中普生物) with Pleiku Bioengineering Co., Ltd. (普莱柯) and CITIC Agricultural Technology Co., Ltd. (中信农业), with Zhongmu holding a 48.99% stake, Pleiku holding 46.97%, and CITIC holding 4.04% [1] Group 1 - Zhongmu plans to relinquish its right of first refusal on the 4.04% stake held by CITIC, which is being offered for sale at no less than RMB 17.5143 million [1] - If Pleiku successfully exercises its subscription rights for the stake, Zhongpu Biopharmaceutical will no longer be a subsidiary controlled by Zhongmu [1]